Cargando…
Effective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2
BACKGROUND: A safe and effective adjuvant plays an important role in the development of a vaccine. However, adjuvants licensed for administration in humans remain limited. Here, for the first time, we developed a novel combination adjuvant alum-polysaccharide-HH2 (APH) with potent immunomodulating a...
Autores principales: | Li, Meng, Shi, Huashan, Mu, Yandong, Luo, Zichao, Zhang, Hailong, Wan, Yang, Zhang, Dongmei, Lu, Lian, Men, Ke, Tian, Yaomei, Wu, Xiaozhe, Liu, Xiaoyan, Pan, Ying, Fan, Yingzi, Yu, Chaoheng, Zhou, Bailing, Xiang, Rong, Chen, Xiancheng, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120012/ https://www.ncbi.nlm.nih.gov/pubmed/25070035 http://dx.doi.org/10.1186/1476-4598-13-179 |
Ejemplares similares
-
The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo
por: Tian, Yaomei, et al.
Publicado: (2017) -
NY-ESO-1 Protein Vaccine Combining Alum, CpG ODN, and HH2 Complex Adjuvant Induces Protective and Therapeutic Anti-Tumor Responses in Murine Multiple Myeloma
por: Wang, Hao, et al.
Publicado: (2020) -
Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria
por: Wu, Xiaozhe, et al.
Publicado: (2017) -
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
por: Thomas, Remy, et al.
Publicado: (2018) -
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells
por: Gong, Wenjie, et al.
Publicado: (2021)